LaLiga Receives R&D+I Certifications For Technological And Innovative Work
By Community | June 26, 2020
LaLiga’s commitment to research, development and technological innovation has been recognised through both the Certification Agency for Spanish Innovation (ACIE) and the European Quality Assurance entity (EQA).
Both organisations, which are accredited certifiers of the ENAC (National Accreditation Body), have recognised several LaLiga projects due to the innovative nature of their technology.
The Calendar Selector tool, designed by LaLiga to optimise television viewing figures and stadium attendance with the use of artificial intelligence, has received recognition as a research and development project. The same certification has been applied to the Marauder, Lumiere and Tyche apps, which were created by LaLiga’s Antipiracy Department to help combat the illegal viewing of matches.
Over 20 projects developed by LaLiga have been certified as technological innovations, including its OTT platform LaLigaSportsTV, the real-time match analytics platform Mediacoach, Horeca (hotel, restaurant and cafe industry-focused), tools developed by the LaLiga BI & analytics department, corporate applications such as the clubs’ portal and the new LaLiga website, among others.
“We’re proud to receive these types of certifications because they validate all the hard work that we are doing within the world of technology at LaLiga. We are firmly committed to innovation and this recognition is a boost for us to continue down this path in the mid- to long-term,” explained LaLiga President Javier Tebas.
The recognition also provides a tax reduction with which LaLiga will be able to support its clubs financially to help them cope through these current uncertain times due to the COVID-19 pandemic.
In addition, these certifications bring to the fore LaLiga’s commitment to investing in technology and innovation, through the creation of new jobs and the use of ground-breaking technology such as the Inferno supercomputer, which is currently being used by biomedical researchers in the fight against COVID-19.